Solar Industries targets INR14,000 cr FY27 revenue

Solar Industries India Limited — Q4 FY26 Earnings Call (May 15, 2026)

1. Overall Tone of Management

Optimistic. Management highlights “landmark performance” and record sales/EBITDA/PAT, and pairs it with confident forward targets: “targeting to achieve a revenue of INR14,000 crores in FY ’27, while maintaining current margins” and “should cross defense revenue of INR4,500 crores in FY ’27.”

2. Key Themes from Management Commentary

• Record growth despite domestic mining softness: Management stresses “Despite no growth in domestic mining markets,” yet delivers highest-ever quarterly/annual sales and profitability.
• Defense and international as primary growth engines:
• Defense “nearly doubled” and defense mix rises sharply (defense in customer basket 33% vs 20% in Q4; 27% vs 18% for FY).
• International grows strongly (international business growth 32% YoY; Q4 international revenue ~INR1,000 cr stated in Q&A).
• Margin resilience amid commodity inflation: EBITDA margins held near guidance levels (Q4 EBITDA margin ~28.5%, FY 27.95%), attributed to “operational efficiencies” and “high-value chain products.”
• Geographic expansion for international footprint + domestic footprint strengthening:
• Africa expansion focus (South Africa hub; Zambia/Tanzania/started Zimbabwe; Nigeria/Ghana; Sierra Leone expected; Turkey/Kazakhstan; Australia “start very soon”).
• Domestic expansion via new/upcoming plants (North/West expansions; plants in East & South upcoming).
• Capex and scaling plan: Invested INR2,700 cr over last 2 years, entering FY27 with planned annual capex INR2,050 cr.
• Order book as confidence anchor: “strong order book of INR21,300 crores” supporting FY27 revenue target.

3. Q&A Analysis

Theme A: International business—new geographies & growth outlook

• Core questions:
• Which new geographies (e.g., Zimbabwe) and where traction is expected in FY27?
• How big is the export opportunity medium-term (2–3 years) and potential growth multiple?
• Management response:
• Focus on Africa expansion: South Africa hub; facilities in Zambia, Tanzania, Zimbabwe; Nigeria base with Ghana operations; Sierra Leone expected; Turkey/Kazakhstan; Australia soon.
• For medium-term export growth: expects ~30% growth next year, but won’t commit to a multiple (“very difficult… give any trajectory specifically in numbers of how much multiple”).
• Qualitative expectation: international markets growing 2–3%, but Solar expects ~10% volume and ~15% value growth; commodity price rise helps value in the near term.
• Assessment (evasive/partial/strong):
• Partial: provides directional growth rates but no market share visibility (“As of now, we don’t have that kind of visibility.”).
• Strong: clear list of operationalizing countries and facility strategy.

Theme B: Defense—product timelines, order visibility, and execution risk

• Core questions:
• Bhargavastra counter-drone: status of trials/tests and when orders can be expected.
• 155mm shells: certifications/tests and when full round supply starts.
• Defense order book breakup and “major orders” expected near term.
• Management response:
• Bhargavastra: “product development is in the final stage”; expects to “complete all the trials in this calendar year.”
• 155mm shells: supplying raw material intermediates already; coupling facility to finish “in next couple of quarters,” then “another 3 to 4 months’ time” before full round supply.
• Order book breakup: defense ~INR18,000 cr and non-defense ~INR3,000 cr (from total INR21,300 cr order book).
• Pinaka: biggest defense order; also expects additional Pinaka series orders “in discussion stage” (negotiation takes time).
• Assessment:
• Unusually strong specificity on timelines for trials and production ramp (calendar year completion; coupling facility + 3–4 months).
• Still cautious on product-specific commercialization beyond milestones (explicitly avoids “product-specific questions” but then answers for Bhargavastra/155mm as “strategic item”).

Theme C: Margins—commodity pass-through, defense mix impact, and quarter-to-quarter variability

• Core questions:
• With defense mix rising, why margin guidance impact vs last year?
• Will commodity price pass-through lag cause margin pressure in Q1/Q2?
• Any inventory gains/losses affecting margins?
• Management response:
• Commodity pass-through: contracts have “rise and fall calculations,” but “there will be some, little bit impact” though defense + international should help maintain margins.
• Quarter-to-quarter: “We run business as a whole, and we don’t wish on quarter-to-quarter basis” (pushes back on timing of margin recoup).
• Inventory: Q4 inventory higher than normal due to geopolitical uncertainty; expects inventory gain in coming quarters; explains price escalation pass-through only on part of increase.
• Assessment:
• Defensive but credible: acknowledges some margin impact risk while emphasizing contract mechanisms and defense/international offset.
• Inventory admission is a notable driver: higher inventory in Q4, normalization expected.

Theme D: Working capital—cash flow swing and normalization timing

• Core questions:
• Large working capital absorption in FY25–26 (swing vs prior year).
• Whether it was deliberate and how it affects future revenue/margins.
• Management response:
• Working capital days rose in Q4 due to “higher inventory levels” built to “mitigate the risk arising from geopolitical uncertainties.”
• Expects normalization “maybe in the next 2 quarters.”
• Assessment:
• Strong transparency: explicitly ties working capital to inventory strategy and geopolitical risk mitigation.

Theme E: Competition and demand—potential new entrants

• Core questions:
• Kalyani Group entry into explosives: competitive intensity?
• Management response:
• Avoids direct competitive commentary (“would not like to comment”), but states Solar is not afraid and emphasizes broader tech/energetic product strategy.
• Assessment:
• Evasive on competition specifics; non-committal but not alarmist.

4. Guidance / Outlook

Explicit guidance (quantitative)

• FY27 revenue target: INR14,000 crores
• FY27 margin stance: “maintaining current margins”
• Defense revenue target: “cross defense revenue of INR4,500 crores in FY ’27”
• Order book: INR21,300 crores (stated as support for targets)
• Capex:
• Invested INR2,700 crores over last 2 years
• Planned annual capex INR2,050 crores in FY27
• International growth (directional but numeric):
• FY27 international expected to do “very good” (no hard number), but management earlier in Q&A: ~30% growth next year for international/exports (context: export business growth).
• Dividend: proposed INR11 per share for FY ’26-’27 (up from INR10 prior year)

Implicit signals (qualitative)

• Defense product commercialization confidence via milestone language:
• Bhargavastra trials completion “in this calendar year”
• 155mm coupling facility completion “in next couple of quarters” and full round supply after “3–4 months”
• Demand outlook: expects domestic coal mining demand to pick up as OB removal bottomed out; also expects shift from diesel/petrol to electricity-based products to support coal sector demand.
• Margin confidence despite commodity risk: relies on contract pass-through mechanics and mix benefits.

5. Standout Statements (most revealing)

• Record performance despite domestic softness: “Despite no growth in domestic mining markets… highest-ever quarterly and annual sales…”
• Defense growth confidence: “defense business has nearly doubled” and “should cross defense revenue of INR4,500 crores in FY ’27.”
• Margin maintenance pledge: “targeting to achieve a revenue of INR14,000 crores in FY ’27, while maintaining current margins.”
• Defense trial/commercialization milestones (specific):
• “complete all the trials in this calendar year” (Bhargavastra)
• “coupling facility… finish in next couple of quarters… another 3 to 4 months’ time” (155mm full round supply)
• Working capital strategy admitted: inventory built to “mitigate the risk arising from geopolitical uncertainties,” with normalization “maybe in the next 2 quarters.”
• Inventory/margin mechanics explained: price escalation pass-through only on “for, say, 60% of the total increase,” with some contracts passing after a quarter.

6. Red Flags / Positive Signals

Red flags
– Limited visibility on market share: “As of now, we don’t have that kind of visibility” (exports).
– Quarter-to-quarter margin timing pushed back: management avoids committing to when commodity pass-through will hit margins (“don’t wish on quarter-to-quarter basis”).
– Competition question deflected: no direct assessment of competitive intensity from new entrants.

Positive signals
– Clear operational milestone timelines for defense products (Bhargavastra trials; 155mm coupling + ramp).
– Working capital normalization window provided (“next 2 quarters”).
– Strong order book coverage (INR21,300 cr) supporting FY27 revenue target.

7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

• Current (Q4 FY26): more confident and execution-focused, with explicit FY27 revenue/margin targets and capex plan.
• Prior (Q2/H1 FY26, Nov 2025): optimistic but more conditional—management referenced “optimistic of reaching our FY ’26 guidance” and emphasized Q3 as “new growth phase.”
• Shift classification: More Optimistic
• More direct commitments now (“targeting INR14,000 cr FY27… maintaining margins”) vs earlier “optimistic” language.
• More milestone specificity in defense commercialization now.

b. Tracking Past Commitments vs Outcomes

• Defense growth phase from Q3 (Nov 2025 call):
• Past statement: Q3 would “herald the new growth phase in defense” and defense ramp from Q3.
• What happened by Q4 FY26 call: defense nearly doubled; defense revenue in Q4 INR1,008 cr and defense mix rose sharply; FY defense revenue INR2,634 cr.
• Flag: ✅ Delivered (at least directionally and materially).
• Bhargavastra trials completion expectation (Aug 2025 / Nov 2025 narrative):
• Past statement (Aug 2025): trials/qualification “a couple of quarters” and commercialization after qualification.
• Current (May 2026): “final stage” and “complete all the trials in this calendar year.”
• Flag: ⏳ Delayed / still in progress (still not fully commercial; now positioned as trials completion in calendar year).
• Capex guidance trajectory (Nov 2025 call):
• Past statement: capex guided higher earlier (FY26 guided INR2,500 cr; H1 capex behind pace due to monsoon).
• Current: FY27 capex planned INR2,050 cr; FY26 capex not explicitly restated in this call, but working capital/inventory suggests operational scaling continued.
• Flag: ⏳ Partially delayed (H1 capex deferment acknowledged in Nov 2025; current call doesn’t correct FY26 capex, but FY26 performance suggests execution still strong).

c. Narrative Shifts

• Defense moved from “ramp-up/qualification” to “milestone completion + commercialization ramp”:
• Earlier calls emphasized trials and “Q3 growth phase.”
• Now management provides trial completion timing and production ramp sequencing (coupling facility + months).
• Domestic mining softness reframed:
• Earlier calls (Q1/Q2 FY26) heavily discussed monsoon impact on domestic demand.
• In Q4 FY26, management says “Despite no growth in domestic mining markets” while still delivering records—implying reliance has shifted further to defense/international.

d. Consistency & Credibility Signals

• Credibility: Medium-High
• Strength: repeated defense ramp narrative appears to be materializing (defense revenue and mix expansion).
• Weakness: some commercialization timelines remain cautious (Bhargavastra still not “orders received,” only trials completion).
• Margin narrative is consistent: commodity pass-through is difficult but contract mechanisms + mix should sustain ~27–28% EBITDA.

e. Evolution of Key Themes

• Demand: domestic mining volatility acknowledged earlier; now less emphasized as a constraint.
• Margins: maintained around high-20s; management increasingly attributes resilience to contract mechanics + mix (defense/international).
• Expansion: international geographic expansion list becomes more concrete (Africa + Turkey/Kazakhstan + Australia).
• Working capital: earlier calls discussed working capital cycle; now explicitly ties Q4 inventory build to geopolitical risk and provides normalization timeline.

f. Additional Insights (cross-period intelligence)

• Geopolitical uncertainty is now operationalized into working capital policy (inventory build in Q4 FY26). This suggests management is proactively managing supply continuity rather than waiting for demand visibility—supportive for revenue stability but can pressure cash conversion until normalization.
• Defense execution appears to be the “buffer” against domestic softness: even when domestic mining growth is absent, consolidated performance remains record—indicating increasing dependence on defense/international for earnings stability.